在 NHLBI Trans-Omics for Precision Medicine 计划中,循环代谢物的遗传架构和分析实践
Nannan Wang1, Franklin P Ockerman2, Laura Y Zhou3
1Department of Epidemiology, The University of Texas Health Science Center at Houston, Houston, TX, USA.
American journal of human genetics
|September 19, 2025
概括
这项研究确定了1775个与667种循环代谢物相关的基因位点,揭示了对人类健康和疾病的新见解. 还发现了性别特异性对代谢物水平的遗传影响.
科学领域:
- 遗传学 是一个遗传学.
- 代谢学 代谢学 代谢学
- 人类健康 人类健康 人类健康
背景情况:
- 循环中的代谢物水平是人类健康和疾病的关键指标,受遗传因素的影响.
- 以前对代谢物的遗传研究往往缺乏祖先多样性,并依赖单个研究分析.
- 美国国家心脏,肺和血液研究所 (NHLBI) 精准医疗的跨奥米学 (TOPMed) 计划提供了广泛的代谢学数据.
研究的目的:
- 在一个祖先多样化的群体中对循环代谢物进行目录和分析.
- 使用全基因组测序数据识别与循环代谢物水平相关的遗传位置.
- 探索性别特异性对代谢物水平的遗传影响.
主要方法:
- 从25058个不同的样本中协调和目录了1,729种循环代谢物.
- 在代谢学数据中开发和比较异常值和归算处理策略.
- 对1135种代谢物进行全基因组关联分析,使用来自16359个人的全基因组测序数据.
主要成果:
- 发现了1,775个与667种代谢物相关的独立位点.
- 确定了160种新的位点-代谢物关联,包括GAB3和VSIG4.4等基因中的基因.
- 在FADS2和UGT2B17等基因中揭示了85种特定于性别的位点-代谢物关联.
结论:
- 遗传因素对各种人群中循环代谢物水平的变化有显著的贡献.
- 这项研究为了解人类代谢组的遗传结构提供了全面的资源.
- 突显代谢调节中的性别差异为精准医学提供了新的途径.
关键词:
在GWAS中,GWAS就是GWAS.在TOPMed中使用.在循环中的代谢产物.一半最小的归算.逆正常转换的正常转换.遇到了QTLs.代谢物目录是代谢物目录.分析了多项研究的分析.性别分层的分析.更多相关视频
03:39Author Spotlight: Multi-Layered Approach to Understand Postnatal Functions of Pancreatic Islets in Non-Human Primates
Published on: November 8, 2024
839
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
907
相关概念视频
Genomics
35.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.6K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
